Startseite
Français
Deutsch
English
linkedin  facebook  

KIF6 Statin Treatment (Pharmacogenetics and Cardiology)

A PHARMAgen product

Statins are among the most widely prescribed drugs for treatment of hypercholesterolemia and prevention of cardiovascular disorders such as coronary heart disease. Carriers of a specific genetic variation in the KIF6 gene are more responsive to certain statins; therefore, this test is recommended prior to statin treatment to evaluate a patient's individual statin tolerance, or to clarify the cause of reported adverse effects.

Downloads

Flyer
Size:0.9 MBytes
Consent Form
Size:156 KBytes
Order Form
Size:553 KBytes